GEODE CAPITAL MANAGEMENT, LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 147 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$168,000
-95.9%
1,491,522
-38.3%
0.00%
-100.0%
Q3 2018$4,109,000
+1.7%
2,417,091
+4.1%
0.00%0.0%
Q2 2018$4,040,000
+8.5%
2,321,991
+14.1%
0.00%0.0%
Q1 2018$3,724,000
-16.0%
2,035,049
+2.3%
0.00%
-50.0%
Q4 2017$4,435,000
-25.0%
1,988,935
-2.4%
0.00%0.0%
Q3 2017$5,911,000
-30.5%
2,038,301
+6.6%
0.00%
-33.3%
Q2 2017$8,507,000
+9.3%
1,911,859
+14.5%
0.00%0.0%
Q1 2017$7,782,000
-13.7%
1,670,188
+12.8%
0.00%
-25.0%
Q4 2016$9,018,000
+20.9%
1,480,953
+9.4%
0.00%0.0%
Q3 2016$7,460,000
+53.7%
1,354,038
+6.0%
0.00%
+33.3%
Q2 2016$4,855,000
+144.5%
1,277,680
+77.5%
0.00%
+200.0%
Q1 2016$1,986,000
-47.3%
719,734
+8.3%
0.00%
-50.0%
Q4 2015$3,767,000
+8.8%
664,407
+1.7%
0.00%0.0%
Q3 2015$3,461,000
-28.6%
653,160
+11.8%
0.00%
-33.3%
Q2 2015$4,850,000
+83.5%
584,425
+2.1%
0.00%
+50.0%
Q1 2015$2,643,000
+61.9%
572,283
+6.9%
0.00%
+100.0%
Q4 2014$1,632,000
+18.7%
535,396
+8.4%
0.00%0.0%
Q3 2014$1,375,000
-30.8%
493,797
+1.2%
0.00%0.0%
Q2 2014$1,986,000
-15.2%
488,121
+10.7%
0.00%
-50.0%
Q1 2014$2,341,000
-3.0%
441,016
+2.9%
0.00%0.0%
Q4 2013$2,413,000
+31.2%
428,653
+6.5%
0.00%
+100.0%
Q3 2013$1,839,000
+17.2%
402,419
+10.8%
0.00%0.0%
Q2 2013$1,569,000363,1410.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q2 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders